Frequent and significant k-ras mutation in the pancreas, the bile duct, and the gallbladder in autoimmune pancreatitis

Pancreas

Volumn 38, Issue 8, 2009, Pages 890-895

  Kamisawa, Terumi ^a   Tsuruta, Kouji ^a   Okamoto, Atsutake ^a   Horiguchi, Shin Ichirou ^a   Hayashi, Yukiko ^a   Yun, Xiaoqing ^b   Yamaguchi, Toshikazu ^b   Sasaki, Tsuneo ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b Division of Clinical Development of Biomedical Laboratories   (Japan)

Author keywords

Autoimmune pancreatitis; Foxp3; IgG4; K ras; Pancreatic cancer

Indexed keywords

IMMUNOGLOBULIN G4; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ALCOHOLIC PANCREATITIS; ARTICLE; AUTOIMMUNE PANCREATITIS; BILE DUCT; CODON; COMMON BILE DUCT; CONTROLLED STUDY; FEMALE; GALLBLADDER; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; PANCREAS CANCER; PANCREAS JUICE; PLASMA CELL; PRIORITY JOURNAL;

AGED; AUTOIMMUNE DISEASES; BILE DUCTS; CHRONIC DISEASE; DIGESTIVE SYSTEM; FEMALE; GALLBLADDER; GENE FREQUENCY; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; PANCREAS; PANCREATIC JUICE; PANCREATITIS; PANCREATITIS, ALCOHOLIC; PLASMA CELLS; RAS PROTEINS;

EID: 70350645176     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181b65a1c     Document Type: Article

References (40)

1. Finkelberg DL, Sahani D, Deshpande V, et al. Autoimmune pancreatitis. N Engl J Med. 2006;355:2670-2676.
2. Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut. 2002;51:1-4.
3. Gardner TB, Chari ST. Autoimmune pancreatitis. Gastroenterol Clin N Am. 2008;37:439-460.
4. Kamisawa T, Okamoto A. Prognosis of autoimmune pancreatitis. J Gastroenterol. 2007;42(suppl):59-62.
5. Inoue H, Miyatani H, Sawada Y, et al. A case of pancreas cancer with autoimmune pancreatitis. Pancreas. 2006;33:208-209.
6. Ghazale A, Chari S. Is autoimmune pancreatitis a risk factor for pancreatic cancer? Pancreas. 2007;35:376.
7. Fukui T, Mitsuyama T, Takaoka M, et al. Pancreatic cancer associated with autoimmune pancreatitis in remission. Intern Med. 2008;47: 151-155.
8. Witkiewicz AK, Kennedy EP, Kennyon L, et al. Synchronous autoimmune pancreatitis and infiltrating pancreatic ductal adenocarcinoma: case report and review of the literature. Human Pathol. 2008;79:630-634.
9. Almoguera C, Shibata D, Forrester K, et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell. 1988; 53:549-554.
10. Smit VTHB, Boot AJ, Smits AMM, et al. K-ras codon 12 mutations occur very frequently in pancreatic adenocarcinoma. Nucleic Acids Res. 1998;16:7773-7782.
11. Yanagisawa A, Ohtake K, Ohnishi K, et al. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasia of pancreas suffering from chronic inflammation. Cancer Res. 1993;53:953-956.
12. Maitra A, Fukushima N, Takaori K, et al. Precursors to invasive pancreatic cancer. Adv Anat Pathol. 2005;12:81-91.
13. Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. N Engl J Med. 1993;328:1433-1437.
14. Otsuki M, Chung JB, Okazaki K, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol. 2008;43:403-408.
15. Kamisawa T, Tu Y, Egawa N, et al. Ductal and acinar differentiation in pancreatic endocrine tumors. Dig Dis Sci. 2002;47:2254-2261.
16. Kamisawa T, Funata N, Hayashi Y, et al. Pathological changes in the non-carcinomatous epithelium of the gallbladder in patients with a relatively long common channel. Gastrointest Endosc. 2004;60:56-60.
17. Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune pancreatitis. J Gastroenterol. 2003;38:282-284.
18. Tada M, Teratani T, Komatsu Y, et al. Quantitative analysis of ras gene mutation in pancreatic juice for diagnosis of pancreatic adenocarcinoma. Dig Dis Sci. 1998;43:15-20.
19. Wada R, Yamaguchi T. K-ras codon 12 mutations of the super-minute dysplasia in Barrett's esophagus by DNA extraction using a microdissection method. Dis Esophagus. 2003;16:214-217.
20. Tada M, Komatsu Y, Kawabe T, et al. Quantitative analysis of K-ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonographyYguided fine needle aspiration: clinical utility for diagnosis of pancreatic tumor. Am J Gastroenterol. 2002;97:2263-2270.
21. Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol. 2001;25:579-586.
22. Luttges J, Diederichs A, Menke MAOH, et al. Ductal lesions in patients with chronic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53. Cancer. 2000;88:2495-2504.
23. Tada M, Ohashi M, Shiratori Y, et al. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology. 1996;110:227-231.
24. Sakashita F, Tanahashi T, Yamaguchi K, et al. Case of pancreatic tail cancer associated with autoimmune pancreatitis. Jpn J Gastroenterol Surg. 2006;39:78-83.
25. Tanaka S, Yoshida H, Ikegami A, et al. Therapeutic procedure and prognosis in patients with autoimmune pancreatitis. J Jpn Panc Soc. 2007;22:663-671.
26. Iida H, Kubota K, Mawatari H, et al. A case of autoimmune pancreatitis developed pancreatic tail cancer. J Jpn Panc Soc. 2008;23:608-614.
27. Raina A, Krasinskas AM, Greer JB, et al. Serum immunoglobulin G fraction 4 levels in pancreatic cancer. Elevation not associated with autoimmune pancreatitis. Arch Pathol Lab Med. 2008;132:48-53.
28. Ghazale A, Chari ST, Smyrk TC, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol. 2007;102:1646-1653.
29. Motojima K, Tsunoda T, Kanematsu T, et al. Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutations in the Kirsten-ras oncogene. Ann Surg. 1991;214:657-662.
30. Watanabe M, Asaka M, Tanaka J, et al. Point mutation of K-ras gene codon 12 in biliary tract tumors. Gastroenterology. 1994;107:1147-1153.
31. Singh MK, Chetri K, Pandey UB, et al. Mutational spectrum of K-ras oncogene among Indian patients with gallbladder cancer. J Gastroenterol Hepatol. 2004;19:916-921.
32. Stork P, Loda M, Bosari S, et al. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction. Oncogene. 1991;6:857-862.
33. Nakazawa T, Ohara H, Sano H, et al. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas. 2005;30:20-25.
34. Kamisawa T, Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol. 2006;41:613-625. (Pubitemid 44288524)
35. Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706-715.
36. Oh HC, Gyu KJ, Wook KJ, et al. Early bile duct cancer in a background of sclerosing cholangitis and autoimmune pancreatitis. Intern Med. 2008;47:2025-2028.
37. Lohr M, Kloppel G, Maisonneuve P, et al. Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis. Neoplasia. 2005;7:17-23.
38. Zen Y, Fujii T, Harada K, et al. TH2 and regulatory immune reactions are increased in immunoglobulin G4-related sclerosing pancreatitis and cholangitis. Hepatology. 2007;45:1538-1546.
39. Moo-Young TA, Larson JW, Belt BA, et al. Tumor-derived TGF-Amediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer. J Immunother. 2009;32:12-21.
40. Granville CA, Memmott RM, Balogh A, et al. A central role for Fozp3+ regulatory T cells in K-rasYdriven lung tumorigenesis. PLoS ONE. 2009;4:e5061.